Company intelligence / Profile preview

Innocreative Capital

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Innocreative Capital is a venture capital firm based in Shanghai, China, that specializes exclusively in the healthcare and life sciences sectors. Founded in 2015, the firm focuses on investing in innovative biotechnology, pharmaceutical, and medical device companies with high growth potential, particularly within the Chinese market. Innocreative Capital provides strategic resources and industry expertise alongside financial backing to help its portfolio companies navigate clinical development and commercialization. Notable investments include major biotech players such as InnoCare Pharma and Allist Pharmaceuticals.

Industry: Investors

Beyond the preview

Go deeper on Innocreative Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innocreative Capital.

Explore the full profile